FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Panel to Discuss Non-Rx Naloxone Spray

[ Price : $8.95]

Federal Register notice: FDA announces a 3/20 joint advisory committee meeting to review an NDA for proposed nonprescription nasal...

Lawsuit Against FDA and Livestock/Poultry Antibiotic Use

[ Price : $8.95]

Several public health advocacy groups sue FDA, challenging its 2021 denial of a citizen petition that sought the withdrawal of med...

FDA Funding Opportunity for Pediatric Device Consortia

[ Price : $8.95]

FDA posts a new funding opportunity for its Pediatric Device Consortia grants program, which is open for applications through 3/29...

New Data Support Carvykti sNDA in Multiple Myeloma

[ Price : $8.95]

Janssen Pharmaceutical says it will submit an NDA supplement for Carvykti (ciltacabtagene autoleucel; cilta-cel) after announcing ...

Vanda Petitions FDA Over Teva Non-BrailleLabeling

[ Price : $8.95]

Vanda Pharmaceuticals petitions FDA to revoke the approval of a Teva ANDA for a generic copy of Vandas Hetlioz (tasimelteon) becau...

FDA Denies Petition on Jakafi Safety Labeling

[ Price : $8.95]

FDA denies a 3/2021 petition filed by Loeb & Loeb that asked the agency to take specific actions concerning the adequacy of safety...

Eschoo Reelected as Ranking Dem on Health Subcommittee

[ Price : $8.95]

Democrat members of the House Energy and Commerce Committee vote Rep. Anna G. Eshoo (D-CA) as ranking Democrat on the Health Subco...

LivaNova Again Recalls LifeSPARC Controller Over Software

[ Price : $8.95]

LivaNova (TandemLife) recalls its LifeSPARC Controller due to a problematic software update that was designed to address a previou...

FDA History Office Now Under Office of Operations

[ Price : $8.95]

Federal Register notice: FDAs Office of Operations (OO), Office of Enterprise Management Services (OEMS) modifies its organization...

Lilly Gets Accelerated Approval for Lymophoma Drug

[ Price : $8.95]

FDA grants Eli Lilly accelerated approval for Jaypirca (pirtobrutinib) for treating certain relapsed or refractory mantle cell lym...